Search Results for: stem cells for MS

TGIF: Guns, stem cells, science weekends reads & good news

Wakabayashi-et-al.-Cell-Stem-Cell-Figure-1F

I’ve got some TGIF recommend reads on stem cells, etc, but first, what a week, right? We need more action on preventing gun violence. It’s a uniquely American health crisis that doesn’t have to be. There’s no real, common sense reason that gun control can’t reduce mass killings of our kids and others like the

TGIF: Guns, stem cells, science weekends reads & good news Read More »

Pending State Medical Boards Group Report on Stem Cell Clinics Could be Game Changer

State-Medical-Boards-stem-cell-draft-recommendations

We have a big problem with clinics in the U.S. selling unproven and non-FDA approved stem cell “treatments” to patients and part of the reason in my view why we have this mess today with upwards of 700 such businesses from coast to coast is that regulators including both the FDA and state medical boards

Pending State Medical Boards Group Report on Stem Cell Clinics Could be Game Changer Read More »

Why did Texas A&M ink big deal with stem cell clinic firm Celltex on exosomes?

Texas-AM-Celltex-deal

The recent news that Texas A&M University has inked a full-blown deal with the direct-to-consumer stem cell clinic firm Celltex struck me as an unusual development. Recently we’ve seen more universities exploring the use of stem cells outside of the traditional FDA clinical trial process that is fundamentally based on an investigational new drug application (IND). Some

Why did Texas A&M ink big deal with stem cell clinic firm Celltex on exosomes? Read More »

Internecine conflicts among direct-to-consumer stem cell firms

Regenexx-blog

Stem cell clinics marketing non-FDA approved therapies directly to consumers have been in various tense situations at times with the FDA or academics over the years, but more recently these stem cell clinic-related firms also appear in conflict with each other sometimes. The most notable recent example of conflict involves Dr. Christopher Centeno of Regenexx

Internecine conflicts among direct-to-consumer stem cell firms Read More »

Stem cells for the flu? Pondering PR email, frailty data from Longeveron

Tompkins-Figure-2A

Stem cells for flu? For me, that idea is new. Some months back there was buzz about the stem cell biotech Longeveron related to its report on early trial data on testing infusions of mesenchymal stem cells for frailty in the aged. Frailty that pops up in some aging folks can manifest in a variety

Stem cells for the flu? Pondering PR email, frailty data from Longeveron Read More »

Predatory clinics push stem cell secret society, deep state conspiracy theory

conspiracy-theory-stem-cells-deep-state-e1516141862445

Did you hear the one about the deep state FDA, big pharma stem cell conspiracy theory? This is the phony idea that the FDA, big pharma, and, heck, sometimes even certain academics (who could that be?) are plotting together as some kind of biomedical secret society or “deep state” to block promising stem cell therapies

Predatory clinics push stem cell secret society, deep state conspiracy theory Read More »

Animated map video shows wildfire spread of US stem cell clinics lacking FDA approval

stem-cell-clinic-animated-map-2010

There are now so many clinics selling non-FDA approved stem cell offerings across the U.S. that tens or hundreds of thousands of patients are at risk. How did we get here? What if we had a way of understanding how stem cell clinics spread across the U.S. in the first place? For example, an animated

Animated map video shows wildfire spread of US stem cell clinics lacking FDA approval Read More »

Perspectives on high-profile stem cell retraction in the making from Kyoto University

IPS-cell-paper-retraction-requested

A researcher working at Kyoto University has reportedly engaged in misconduct leading to an institutional request for retraction of a paper from the journal Stem Cell Reports. The paper in question appears to have rather large-scale problems: “Kohei Yamamizu, a specially appointed assistant professor at the university’s Center for iPS Cell Research and Application, falsified all

Perspectives on high-profile stem cell retraction in the making from Kyoto University Read More »